Trial intelligence / Profile preview

Intra-abdominal Ropivacaine Spray for Postoperative Pain in Laparoscopic Surgery

NCT05173090Unknown

Sponsor
University of Liège
Start
Jan 2022
Primary completion
Jun 2022
Modality
Orthosteric Ligands
01

Overview

Randomised, single-blind trial of ropivacaine in acute pain (2 arms), sponsored by University of Liège. Primary endpoint: Patient's pain at 1 week. Status: unknown.

02

Drugs

ropivacaine
03

Conditions

acute pain

Beyond the preview

Go deeper on NCT05173090.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05173090.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call